Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424 (Dienogest 2 mg / Ethinyl Estradiol 0.02 mg) During 13 Cycles

NCT03945513 is registered in ClinicalTrials.gov with Insud Pharma as lead sponsor.

NCT NCT03945513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03945513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424 (Dienogest 2 mg / Ethinyl Estradiol 0.02 mg) During 13 Cycles
Lead sponsor
Insud Pharma
Phase
Phase 3
Overall status
Completed
Start date
December 3, 2019
Completion date
September 8, 2023
Enrollment
1,034 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception